US Patent 11401286 Heteroaryl inhibitors of PDE4
Patent 11401286 was granted and assigned to Tetra Therapeutics on August, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11401286 Heteroaryl inhibitors of PDE4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.